Combivir Related Clinical Trials
GW873140 In Combination With Combivir In HIV Infected Subjects [Terminated]
Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR [Completed]
A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV [Completed]
Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects [Active, not recruiting]
Study of Combivir for Patients With Primary Biliary Cirrhosis [Completed]
SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection [Active, not recruiting]
Tenofovir Disoproxil Fumarate (DF)/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects [Active, not recruiting]
Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir) [Active, not recruiting]
Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients [Suspended]
Atazanavir or Lopinavir in HIV Post-Exposure Prophylaxis [Not yet recruiting]
A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs [Completed]
Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal [Not yet recruiting]
Backup With Combivir or Single Dose (Sd) Truvada in Order to Avoid NNRTI Resistance After Sd Nevirapine for the PMTCT [Recruiting]
Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, China [Completed]
Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV [Recruiting]
A Study of Single Dose NVP With 4 or 7 Day Course of Combivir for pMTCT - Treatment Options Preservation Study (TOPS) [Completed]
Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen [Completed]
A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults [Completed]
Safety Of VIRACEPT; 625 mg Administered To HIV-Infected Women During Pregnancy [Completed]
Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-Partum Phase. ANRS 135 Primeva [Recruiting]
Zidovudine and Lamivudine Given Once Versus Twice Daily [Active, not recruiting]
A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment [Completed]
A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects [Completed]
A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients [Completed]
Combination of Efavirenz and Truvada - COMET Study [Completed]
Bioavailability Study of a New Pediatric Formulation of Zidovudine/Lamivudine in Adult Volunteers [Recruiting]
Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral NaŃ—ve Patients [Completed]
Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection [Completed]
Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune) [Active, not recruiting]
A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients [Completed]
Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti [Recruiting]
Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV [Active, not recruiting]
Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy [Recruiting]
Breastfeeding, Antiretroviral, and Nutrition Study [Recruiting]
NRTI-Sparing Pilot Study [Active, not recruiting]
FREE Study: Efficacy and Toxicity of Trizivir [Recruiting]
Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women [Recruiting]
Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma [Active, not recruiting]
A Study of Two Anti-HIV Drug Combinations [Completed]
An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C [Completed]
Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects [Completed]
The Effect of Teaching HIV-Infected Patients About HIV and Treatment [Completed]
Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis [Recruiting]
Preventing Sexual Transmission of HIV With Anti-HIV Drugs [Recruiting]
A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients [Completed]
A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood [Terminated]
A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure [Completed]
A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection [Completed]
Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV [Completed]
Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs [Active, not recruiting]
Changing to Nonprotease Inhibitor Treatment to Improve Side Effects [Completed]
Increasing HAART-Induced Immune Restoration With Cyclosporine [Completed]
A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past [Completed]
Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients [Suspended]
Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen [Completed]
Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy [Completed]
A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients [Terminated]
Clinical Trial of CNS-Targeted HAART (CIT2) [Recruiting]
Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women [Not yet recruiting]
|
